Baranowski Lyn

Chief Executive Officer at AVLN

Sold, on record
$1.5M
Dollars the filings state
Form 4 sales
1
Latest Nov 18, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • AVLNAvalyn Pharma Inc.Chief Executive Officer

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale AVLNRoutine
    Nov 18 2026

    Sold 52,500 shares at $27.84 ($1.5M)

    Baranowski Lyn, Chief Executive Officer

    10b5-1 planSold 100% of holdings ($1.5M position)0 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Baranowski Lyn
Source
Nov 18, 2026AVLNChief Executive OfficerForm 4 sale52,500$1.5M100.0%RoutineSEC